Skip to main content
SpringerLink
Log in

Oxidative Stress and Drug Resistance in Cancer

  • Chapter
  • First Online:
Drug Resistance in Cancer Cells

Abstract

Increased generation of reactive oxygen species (ROS) is observed in many types of cancer cells. Besides the well-recognized effect of ROS in causing mutations and promoting cancer cell growth, recent evidence further suggests the involvement of oxidative stress in anticancer drug resistance. Consistent with the tumor-promoting effect of ROS, many in vitro studies have reported tumor-suppressing properties of ROS-scavenging enzymes. However, enhancement of those enzymes in tumor cells in vivo has been implicated in chemoresistance and seems to be associated with poor prognosis. In this chapter, we summarized the relevant observations in the field and discuss evidences that may explain these seemingly paradoxical findings. Malignant transformation is often associated with a moderate increase in cellular ROS content as a result of evelvated ROS production and/or decreased ROS-scavenging capacity. Because the increase in ROS stress may induce oxidative damage of cellular components leading to cell death, cancer cells that are able to survive the intrinsic stress and develop tumor must be equipped with sufficient adaptive mechanisms to tolerate the ROS stress. The adaptation processes involve activation of certain redox-sensitive transcription factors, which consequently lead to increased expression of the downstream genes encoding various ROS-scavenging enzymes, and redox-sensitive survival machineries. These adaptation mechanisms lead to increase in cell survival capacity in response to stress and alteration in drug metabolism and transport, which together confer drug resistance. Therefore, strategies to modulate cellular adaptation to oxidative stress may be used as an effective approach to overcome drug resistance in cancer cells under intrinsic stress.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Achanta, G., and Huang, P. 2004. Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents. Cancer Res. 64:6233–6239.

    PubMed  CAS  Google Scholar 

  • Achanta, G., Sasaki, R., Feng, L., Carew, J. S., Lu, W., Pelicano, H., Keating, M. J., and Huang, P. 2005. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. Embo J. 24:3482–3492.

    PubMed  CAS  Google Scholar 

  • Adams, J. 2002. Proteasome inhibition: a novel approach to cancer therapy. Trends Mol Med. 8:S49–54.

    PubMed  CAS  Google Scholar 

  • Ahmad, S., Okine, L., Wood, R., Aljian, J., and Vistica, D. T. 1987. gamma-Glutamyl transpeptidase (gamma-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents. J Cell Physiol. 131:240–246.

    PubMed  CAS  Google Scholar 

  • Ali-Osman, F. 1989. Quenching of DNA cross-link precursors of chloroethylnitrosoureas and attenuation of DNA interstrand cross-linking by glutathione. Cancer Res. 49:5258–5261.

    PubMed  CAS  Google Scholar 

  • Angel, P., and Karin, M. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1072:129–157.

    PubMed  CAS  Google Scholar 

  • Ariga, A., Namekawa, J., Matsumoto, N., Inoue, J., and Umezawa, K. 2002. Inhibition of tumor necrosis factor-alpha -induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin. J Biol Chem. 277:24625–24630.

    PubMed  CAS  Google Scholar 

  • Arnold, N. B., Ketterer, K., Kleeff, J., Friess, H., Buchler, M. W., and Korc, M. 2004. Thioredoxin is downstream of Smad7 in a pathway that promotes growth and suppresses cisplatin-induced apoptosis in pancreatic cancer. Cancer Res. 64:3599–3606.

    PubMed  CAS  Google Scholar 

  • Asumendi, A., Morales, M. C., Alvarez, A., Arechaga, J., and Perez-Yarza, G. 2002. Implication of mitochondria-derived ROS and cardiolipin peroxidation in N-(4-hydroxyphenyl)retinamide-induced apoptosis. Br J Cancer. 86:1951–1956.

    PubMed  CAS  Google Scholar 

  • Attardi, L. D., and Donehower, L. A. 2005. Probing p53 biological functions through the use of genetically engineered mouse models. Mutat Res. 576:4–21.

    PubMed  CAS  Google Scholar 

  • Azad, N., Rojanasakul, Y., and Vallyathan, V. 2008. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev. 11:1–15.

    PubMed  CAS  Google Scholar 

  • Bailey, H. H., Mulcahy, R. T., Tutsch, K. D., Arzoomanian, R. Z., Alberti, D., Tombes, M. B., Wilding, G., Pomplun, M., and Spriggs, D. R. 1994. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione. J Clin Oncol. 12:194–205.

    PubMed  CAS  Google Scholar 

  • Balendiran, G. K., Dabur, R., and Fraser, D. 2004. The role of glutathione in cancer. Cell Biochem Funct. 22:343–352.

    PubMed  CAS  Google Scholar 

  • Barranco, S. C., Townsend, C. M., Jr., Weintraub, B., Beasley, E. G., MacLean, K. K., Shaeffer, J., Liu, N. H., and Schellenberg, K. 1990. Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro. Cancer Res. 50:3614–3618.

    PubMed  CAS  Google Scholar 

  • Bates, S. E., Regis, J. I., Robey, R. W., Zhan, Z., Scala, S., and Meadows, B. J. 1994. Chemoresistance in the clinic: overview 1994. Bull Cancer. 81 Suppl 2:55s-61s.

    PubMed  Google Scholar 

  • Bea, F., Hudson, F. N., Chait, A., Kavanagh, T. J., and Rosenfeld, M. E. 2003. Induction of Glutathione Synthesis in Macrophages by Oxidized Low-Density Lipoproteins Is Mediated by Consensus Antioxidant Response Elements. Circ Res. 92:386–393.

    PubMed  CAS  Google Scholar 

  • Bedford, P., Fichtinger-Schepman, A. M., Shellard, S. A., Walker, M. C., Masters, J. R., and Hill, B. T. 1988. Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines. Cancer Res. 48:3019–3024.

    PubMed  CAS  Google Scholar 

  • Behrend, L., Henderson, G., and Zwacka, R. M. 2003. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans. 31:1441–1444.

    PubMed  CAS  Google Scholar 

  • Benassi, B., Fanciulli, M., Fiorentino, F., Porrello, A., Chiorino, G., Loda, M., Zupi, G., and Biroccio, A. 2006. c-Myc phosphorylation is required for cellular response to oxidative stress. Mol Cell. 21:509–519.

    PubMed  CAS  Google Scholar 

  • Benlloch, M., Mena, S., Ferrer, P., Obrador, E., Asensi, M., Pellicer, J. A., Carretero, J., Ortega, A., and Estrela, J. M. 2006. Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-alpha and chemotherapy. J Biol Chem. 281:69–79.

    PubMed  CAS  Google Scholar 

  • Bours, V., Dejardin, E., Goujon-Letawe, F., Merville, M. P., and Castronovo, V. 1994. The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines. Biochem Pharmacol. 47:145–149.

    PubMed  CAS  Google Scholar 

  • Bracht, K., Liebeke, M., Ritter, C. A., Grunert, R., and Bednarski, P. J. 2007. Correlations between the activities of 19 standard anticancer agents, antioxidative enzyme activities and the expression of ATP-binding cassette transporters: comparison with the National Cancer Institute data. Anticancer Drugs. 18:389–404.

    PubMed  CAS  Google Scholar 

  • Bragado, P., Armesilla, A., Silva, A., and Porras, A. 2007. Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation. Apoptosis. 12:1733–1742.

    PubMed  CAS  Google Scholar 

  • Brahimi-Horn, M. C., and Pouyssegur, J. 2007. Oxygen, a source of life and stress. FEBS Lett. 581:3582–3591.

    PubMed  CAS  Google Scholar 

  • Brand, M. D., and Esteves, T. C. 2005. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab. 2:85–93.

    PubMed  CAS  Google Scholar 

  • Brown, K. K., Eriksson, S. E., Arner, E. S., and Hampton, M. B. 2008. Mitochondrial peroxiredoxin 3 is rapidly oxidized in cells treated with isothiocyanates. Free Radic Biol Med. 45: 494–502.

    PubMed  CAS  Google Scholar 

  • Busuttil, R. A., Garcia, A. M., Cabrera, C., Rodriguez, A., Suh, Y., Kim, W. H., Huang, T. T., and Vijg, J. 2005. Organ-specific increase in mutation accumulation and apoptosis rate in CuZn-superoxide dismutase-deficient mice. Cancer Res. 65:11271–11275.

    PubMed  CAS  Google Scholar 

  • Cai, Y., Lu, J., Miao, Z., Lin, L., and Ding, J. 2007. Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells. Cancer Biol Ther. 6:1794–1799.

    PubMed  CAS  Google Scholar 

  • Carew, J. S., Zhou, Y., Albitar, M., Carew, J. D., Keating, M. J., and Huang, P. 2003. Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Leukemia. 17:1437–1447.

    PubMed  CAS  Google Scholar 

  • Chauhan, D., Neri, P., Velankar, M., Podar, K., Hideshima, T., Fulciniti, M., Tassone, P., Raje, N., Mitsiades, C., Mitsiades, N., et al. 2007. Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM). Blood. 109:1220–1227.

    PubMed  CAS  Google Scholar 

  • Chen, G., Hutter, K. J., and Zeller, W. J. 1995. Positive correlation between cellular glutathione and acquired cisplatin resistance in human ovarian cancer cells. Cell Biol Toxicol. 11:273–281.

    PubMed  CAS  Google Scholar 

  • Chen, Y. R., Han, J., Kori, R., Kong, A. N., and Tan, T. H. 2002. Phenylethyl isothiocyanate induces apoptotic signaling via suppressing phosphatase activity against c-Jun N-terminal kinase. J Biol Chem. 277:39334–39342.

    PubMed  CAS  Google Scholar 

  • Chen, Z., Trotman, L. C., Shaffer, D., Lin, H. K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. 2005. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 436:725–730.

    PubMed  CAS  Google Scholar 

  • Chiera, F., Meccia, E., Degan, P., Aquilina, G., Pietraforte, D., Minetti, M., Lambeth, D., and Bignami, M. 2008. Overexpression of human NOX1 complex induces genome instability in mammalian cells. Free Radic Biol Med. 44:332–342.

    PubMed  CAS  Google Scholar 

  • Cho, H. Y., Reddy, S. P., and Kleeberger, S. R. 2006. Nrf2 defends the lung from oxidative stress. Antioxid Redox Signal. 8:76–87.

    PubMed  CAS  Google Scholar 

  • Choi, C. H., Kim, H. S., Kweon, O. S., Lee, T. B., You, H. J., Rha, H. S., Jeong, J. H., Lim, D. Y., Min, Y. D., Kim, M. S., and Chung, M. H. 2000. Reactive oxygen species-specific mechanisms of drug resistance in paraquat-resistant acute myelogenous leukemia sublines. Mol Cells. 10:38–46.

    PubMed  CAS  Google Scholar 

  • Choi, J., Liu, R. M., and Forman, H. J. 1997. Adaptation to oxidative stress: quinone-mediated protection of signaling in rat lung epithelial L2 cells. Biochem Pharmacol. 53:987–993.

    PubMed  CAS  Google Scholar 

  • Clement, M. V., Hirpara, J. L., and Pervaiz, S. 2003. Decrease in intracellular superoxide sensitizes Bcl-2-overexpressing tumor cells to receptor and drug-induced apoptosis independent of the mitochondria. Cell Death Differ. 10:1273–1285.

    PubMed  CAS  Google Scholar 

  • Clement, M. V., and Pervaiz, S. 2001. Intracellular superoxide and hydrogen peroxide concentrations: a critical balance that determines survival or death. Redox Rep. 6:211–214.

    PubMed  CAS  Google Scholar 

  • Clement, M. V., Ponton, A., and Pervaiz, S. 1998. Apoptosis induced by hydrogen peroxide is mediated by decreased superoxide anion concentration and reduction of intracellular milieu. FEBS Lett. 440:13–18.

    PubMed  CAS  Google Scholar 

  • Clement, M. V., and Stamenkovic, I. 1996. Superoxide anion is a natural inhibitor of FAS-mediated cell death. Embo J. 15:216–225.

    PubMed  CAS  Google Scholar 

  • Collins, P., Jones, C., Choudhury, S., Damelin, L., and Hodgson, H. 2005. Increased expression of uncoupling protein 2 in HepG2 cells attenuates oxidative damage and apoptosis. Liver Int. 25:880–887.

    PubMed  CAS  Google Scholar 

  • Craiu, A., Gaczynska, M., Akopian, T., Gramm, C. F., Fenteany, G., Goldberg, A. L., and Rock, K. L. 1997. Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J Biol Chem. 272:13437–13445.

    PubMed  CAS  Google Scholar 

  • Cullinan, S. B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R. J., and Diehl, J. A. 2003. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol. 23:7198–7209.

    PubMed  CAS  Google Scholar 

  • Dasmahapatra, G., Nguyen, T. K., Dent, P., and Grant, S. 2006. Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl. Leuk Res. 30:1263–1272.

    PubMed  CAS  Google Scholar 

  • Daubeuf, S., Leroy, P., Paolicchi, A., Pompella, A., Wellman, M., Galteau, M. M., and Visvikis, A. 2002. Enhanced resistance of HeLa cells to cisplatin by overexpression of [gamma]-glutamyltransferase. Biochemical Pharmacology. 64:207–216.

    PubMed  CAS  Google Scholar 

  • Derdak, Z., Mark, N. M., Beldi, G., Robson, S. C., Wands, J. R., and Baffy, G. 2008. The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells. Cancer Res. 68: 2813–2819.

    PubMed  CAS  Google Scholar 

  • Ding, B., Chi, S. G., Kim, S. H., Kang, S., Cho, J. H., Kim, D. S., and Cho, N. H. 2007. Role of p53 in antioxidant defense of HPV-positive cervical carcinoma cells following H2O2 exposure. J Cell Sci. 120:2284–2294.

    PubMed  CAS  Google Scholar 

  • Efferth, T., Giaisi, M., Merling, A., Krammer, P. H., and Li-Weber, M. 2007. Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells. PLoS ONE. 2:e693.

    PubMed  Google Scholar 

  • Elchuri, S., Oberley, T. D., Qi, W., Eisenstein, R. S., Jackson Roberts, L., Van Remmen, H., Epstein, C. J., and Huang, T. T. 2005. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene. 24:367–380.

    PubMed  CAS  Google Scholar 

  • Ellerby, L. M., Ellerby, H. M., Park, S. M., Holleran, A. L., Murphy, A. N., Fiskum, G., Kane, D. J., Testa, M. P., Kayalar, C., and Bredesen, D. E. 1996. Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2. J Neurochem. 67:1259–1267.

    PubMed  CAS  Google Scholar 

  • England, K., and Cotter, T. G. 2005. Direct oxidative modifications of signalling proteins in mammalian cells and their effects on apoptosis. Redox Rep. 10:237–245.

    PubMed  CAS  Google Scholar 

  • Estrela, J. M., Ortega, A., and Obrador, E. 2006. Glutathione in Cancer Biology and Therapy. Crit Rev Clin Lab Sci. 43:143–181.

    PubMed  CAS  Google Scholar 

  • Estrov, Z., Shishodia, S., Faderl, S., Harris, D., Van, Q., Kantarjian, H. M., Talpaz, M., and Aggarwal, B. B. 2003. Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood. 102:987–995.

    PubMed  CAS  Google Scholar 

  • Fandy, T. E., Shankar, S., and Srivastava, R. K. 2008. Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells. Mol Cancer. 7:60.

    PubMed  Google Scholar 

  • Fantin, V. R., St-Pierre, J., and Leder, P. 2006. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 9: 425–434.

    PubMed  CAS  Google Scholar 

  • Faraonio, R., Vergara, P., Di Marzo, D., Pierantoni, M. G., Napolitano, M., Russo, T., and Cimino, F. 2006. p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. J Biol Chem. 281:39776–39784.

    PubMed  CAS  Google Scholar 

  • Felsher, D. W., and Bishop, J. M. 1999. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc Natl Acad Sci U S A. 96:3940–3944.

    PubMed  CAS  Google Scholar 

  • Fischer, U., Janssen, K., and Schulze-Osthoff, K. 2007. Cutting-edge apoptosis-based therapeutics: a panacea for cancer? BioDrugs. 21:273–297.

    PubMed  CAS  Google Scholar 

  • Franco, R., Schoneveld, O., Georgakilas, A. G., and Panayiotidis, M. I. 2008. Oxidative stress, DNA methylation and carcinogenesis. Cancer Letters. 266:6–11.

    PubMed  CAS  Google Scholar 

  • Fruehauf, J. P., and Meyskens, F. L., Jr. 2007. Reactive oxygen species: a breath of life or death? Clin Cancer Res. 13:789–794.

    PubMed  CAS  Google Scholar 

  • Fulda, S., and Debatin, K. M. 2007. HIF-1-regulated glucose metabolism: a key to apoptosis resistance? Cell Cycle. 6:790–792.

    PubMed  CAS  Google Scholar 

  • Fulton, A. M., and Chong, Y. C. 1992. The role of macrophage-derived TNFa in the induction of sublethal tumor cell DNA damage. Carcinogenesis. 13:77–81.

    PubMed  CAS  Google Scholar 

  • Furusawa, S., Kimura, E., Kisara, S., Nakano, S., Murata, R., Tanaka, Y., Sakaguchi, S., Takayanagi, M., Takayanagi, Y., and Sasaki, K. 2001. Mechanism of resistance to oxidative stress in doxorubicin resistant cells. Biol Pharm Bull. 24:474–479.

    PubMed  CAS  Google Scholar 

  • Gallego, M. A., Ballot, C., Kluza, J., Hajji, N., Martoriati, A., Castera, L., Cuevas, C., Formstecher, P., Joseph, B., Kroemer, G., et al. 2008. Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathway. Oncogene. 27:1981–1992.

    PubMed  CAS  Google Scholar 

  • Gariboldi, M. B., Terni, F., Ravizza, R., Meschini, S., Marra, M., Condello, M., Arancia, G., and Monti, E. 2006. The nitroxide Tempol modulates anthracycline resistance in breast cancer cells. Free Radic Biol Med. 40:1409–1418.

    PubMed  CAS  Google Scholar 

  • Gauss, K. A., Nelson-Overton, L. K., Siemsen, D. W., Gao, Y., DeLeo, F. R., and Quinn, M. T. 2007. Role of NF-kappaB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-alpha. J Leukoc Biol. 82:729–741.

    PubMed  CAS  Google Scholar 

  • Gehrt, A., Erkel, G., Anke, T., and Sterner, O. 1998. Cycloepoxydon, 1-hydroxy-2-hydroxymethyl-3-pent-1-enylbenzene and 1-hydroxy-2-hydroxymethyl-3-pent-1,3-dienylbenzene, new inhibitors of eukaryotic signal transduction. J Antibiot (Tokyo). 51:455–463.

    CAS  Google Scholar 

  • Ghezzi, P. 2005. Review: Regulation of protein function by glutathionylation. Free Radical Research. 39:573–580.

    PubMed  CAS  Google Scholar 

  • Giorgio, M., Migliaccio, E., Orsini, F., Paolucci, D., Moroni, M., Contursi, C., Pelliccia, G., Luzi, L., Minucci, S., Marcaccio, M., et al. 2005. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell. 122: 221–233.

    PubMed  CAS  Google Scholar 

  • Godwin, A. K., Meister, A., O’Dwyer, P. J., Huang, C. S., Hamilton, T. C., and Anderson, M. E. 1992. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci U S A. 89:3070–3074.

    PubMed  CAS  Google Scholar 

  • Gogvadze, V., Orrenius, S., and Zhivotovsky, B. 2006. Multiple pathways of cytochrome c release from mitochondria in apoptosis. Biochim Biophys Acta. 1757:639–647.

    PubMed  CAS  Google Scholar 

  • Golab, J., Nowis, D., Skrzycki, M., Czeczot, H., Baranczyk-Kuzma, A., Wilczynski, G. M., Makowski, M., Mroz, P., Kozar, K., Kaminski, R., et al. 2003. Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor. J Biol Chem. 278:407–414.

    PubMed  Google Scholar 

  • Gout, P. W., Simms, C. R., and Robertson, M. C. 2003. In vitro studies on the lymphoma growth-inhibitory activity of sulfasalazine. Anticancer Drugs. 14:21–29.

    PubMed  CAS  Google Scholar 

  • Green, R. M., Graham, M., R.O’Donovan, M., Chipman, J. K., and J.Hodges, N. 2006. Subcellular compartmentalization of glutathione: Correlations with parameters of oxidative stress related to genotoxicity. Mutagenesis. 21:383–390.

    PubMed  CAS  Google Scholar 

  • Griffith, O. W., and Meister, A. 1979. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem. 254:7558–7560.

    PubMed  CAS  Google Scholar 

  • Haddad, J. J. 2002. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal. 14:879–897.

    PubMed  CAS  Google Scholar 

  • Halliwell, B. 2000. A super way to kill cancer cells? Nat Med. 6:1105–1106.

    PubMed  CAS  Google Scholar 

  • Halliwell, B. 2007. Oxidative stress and cancer: have we moved forward? Biochem J. 401: 1–11.

    PubMed  CAS  Google Scholar 

  • Hampton, M. B., Fadeel, B., and Orrenius, S. 1998. Redox regulation of the caspases during apoptosis. Ann N Y Acad Sci. 854:328–335.

    PubMed  CAS  Google Scholar 

  • Hampton, M. B., and Orrenius, S. 1997. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett. 414:552–556.

    PubMed  CAS  Google Scholar 

  • Han, H., Bearss, D. J., Browne, L. W., Calaluce, R., Nagle, R. B., and Von Hoff, D. D. 2002. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res. 62:2890–2896.

    PubMed  CAS  Google Scholar 

  • Hanahan, D., and Weinberg, R. A. 2000. The hallmarks of cancer. Cell. 100:57–70.

    PubMed  CAS  Google Scholar 

  • Hancock, J. T., Desikan, R., and Neill, S. J. 2001. Does the redox status of cytochrome C act as a fail-safe mechanism in the regulation of programmed cell death? Free Radic Biol Med. 31:697–703.

    PubMed  CAS  Google Scholar 

  • Hannes Hentze, G. K. C. V. W. E. A. W. 1999. CD95-mediated murine hepatic apoptosis requires an intact glutathione status. Hepatology. 30:177–185.

    Google Scholar 

  • Hansson, J., Lewensohn, R., Ringborg, U., and Nilsson, B. 1987. Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells. Cancer Res. 47:2631–2637.

    PubMed  CAS  Google Scholar 

  • Harbottle, A., Daly, A. K., Atherton, K., and Campbell, F. C. 2001. Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance. Int J Cancer. 92:777–783.

    PubMed  CAS  Google Scholar 

  • Harper, M. E., Antoniou, A., Villalobos-Menuey, E., Russo, A., Trauger, R., Vendemelio, M., George, A., Bartholomew, R., Carlo, D., Shaikh, A., et al. 2002. Characterization of a novel metabolic strategy used by drug-resistant tumor cells. Faseb J. 16:1550–1557.

    PubMed  CAS  Google Scholar 

  • Haupt, Y., Maya, R., Kazaz, A., and Oren, M. 1997. Mdm2 promotes the rapid degradation of p53. Nature. 387:296–299.

    PubMed  CAS  Google Scholar 

  • Hayden, M. S., and Ghosh, S. 2004. Signaling to NF-kappaB. Genes Dev. 18:2195–2224.

    PubMed  CAS  Google Scholar 

  • Hentze, H., Kunstle, G., Volbracht, C., Ertel, W., and Wendel, A. 1999. CD95-Mediated murine hepatic apoptosis requires an intact glutathione status. Hepatology. 30:177–185.

    PubMed  CAS  Google Scholar 

  • Holmes-McNary, M., and Baldwin, A. S., Jr. 2000. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res. 60:3477–3483.

    PubMed  CAS  Google Scholar 

  • Horn, H. F., and Vousden, K. H. 2007. Coping with stress: multiple ways to activate p53. Oncogene. 26:1306–1316.

    PubMed  CAS  Google Scholar 

  • Hoshida, Y., Moriyama, M., Otsuka, M., Kato, N., Taniguchi, H., Shiratori, Y., Seki, N., and Omata, M. 2007. Gene expressions associated with chemosensitivity in human hepatoma cells. Hepatogastroenterology. 54:489–492.

    PubMed  CAS  Google Scholar 

  • Hu, Y., Rosen, D. G., Zhou, Y., Feng, L., Yang, G., Liu, J., and Huang, P. 2005. Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress. J Biol Chem. 280:39485–39492.

    PubMed  CAS  Google Scholar 

  • Huang, P., Feng, L., Oldham, E. A., Keating, M. J., and Plunkett, W. 2000. Superoxide dismutase as a target for the selective killing of cancer cells. Nature. 407:390–395.

    PubMed  CAS  Google Scholar 

  • Hug, H., Strand, S., Grambihler, A., Galle, J., Hack, V., Stremmel, W., Krammer, P. H., and Galle, P. R. 1997. Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem. 272:28191–28193.

    PubMed  CAS  Google Scholar 

  • Indo, H. P., Davidson, M., Yen, H. C., Suenaga, S., Tomita, K., Nishii, T., Higuchi, M., Koga, Y., Ozawa, T., and Majima, H. J. 2007. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion. 7: 106–118.

    PubMed  CAS  Google Scholar 

  • Inoue, J., Gohda, J., Akiyama, T., and Semba, K. 2007. NF-kappaB activation in development and progression of cancer. Cancer Sci. 98:268–274.

    PubMed  CAS  Google Scholar 

  • Irani, K., Xia, Y., Zweier, J. L., Sollott, S. J., Der, C. J., Fearon, E. R., Sundaresan, M., Finkel, T., and Goldschmidt-Clermont, P. J. 1997. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 275:1649–1652.

    PubMed  CAS  Google Scholar 

  • Irmak, M. B., Ince, G., Ozturk, M., and Cetin-Atalay, R. 2003. Acquired tolerance of hepatocellular carcinoma cells to selenium deficiency: a selective survival mechanism? Cancer Res. 63:6707–6715.

    PubMed  CAS  Google Scholar 

  • Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S., and Yamamoto, M. 2000. Transcription Factor Nrf2 Coordinately Regulates a Group of Oxidative Stress-inducible Genes in Macrophages. J Biol Chem. 275:16023–16029.

    PubMed  CAS  Google Scholar 

  • Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y., and Hayashi, J. 2008. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 320:661–664.

    PubMed  CAS  Google Scholar 

  • Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., and Yamamoto, M. 1999. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13:76–86.

    PubMed  CAS  Google Scholar 

  • Jeon, K. I., Byun, M. S., and Jue, D. M. 2003. Gold compound auranofin inhibits IkappaB kinase (IKK) by modifying Cys-179 of IKKbeta subunit. Exp Mol Med. 35:61–66.

    PubMed  CAS  Google Scholar 

  • Kakolyris, S., Giatromanolaki, A., Koukourakis, M., Powis, G., Souglakos, J., Sivridis, E., Georgoulias, V., Gatter, K. C., and Harris, A. L. 2001. Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer. Clin Cancer Res. 7:3087–3091.

    PubMed  CAS  Google Scholar 

  • Kalinina, E. V., Chernov, N. N., Saprin, A. N., Kotova, Y. N., Andreev, Y. A., Solomka, V. S., and Scherbak, N. P. 2006. Changes in expression of genes encoding antioxidant enzymes, heme oxygenase-1, Bcl-2, and Bcl-xl and in level of reactive oxygen species in tumor cells resistant to doxorubicin. Biochemistry (Mosc). 71:1200–1206.

    CAS  Google Scholar 

  • Kalinina, E. V., Chernov, N. N., Saprin, A. N., Kotova, Y. N., Gavrilova, Y. A., Chermnykh, N. S., and Shcherbak, N. P. 2007. Expression of genes for thioredoxin 1 and thioredoxin 2 in multidrug resistance ovarian carcinoma cells SKVLB. Bull Exp Biol Med. 144:301–303.

    PubMed  CAS  Google Scholar 

  • Kamiguti, A. S., Serrander, L., Lin, K., Harris, R. J., Cawley, J. C., Allsup, D. J., Slupsky, J. R., Krause, K. H., and Zuzel, M. 2005. Expression and activity of NOX5 in the circulating malignant B cells of hairy cell leukemia. J Immunol. 175:8424–8430.

    PubMed  CAS  Google Scholar 

  • Kaplowitz, N., Aw, T. Y., and Ookhtens, M. 1985. The regulation of hepatic glutathione. Annu Rev Pharmacol Toxicol. 25:715–744.

    PubMed  CAS  Google Scholar 

  • Karin, M., and Lin, A. 2002. NF-kappaB at the crossroads of life and death. Nat Immunol. 3: 221–227.

    PubMed  CAS  Google Scholar 

  • Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., and Green, D. R. 1998. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol Cell. 1:543–551.

    PubMed  CAS  Google Scholar 

  • Kasibhatla, S., Genestier, L., and Green, D. R. 1999. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. J Biol Chem. 274:987–992.

    PubMed  CAS  Google Scholar 

  • Katsman, A., Umezawa, K., and Bonavida, B. 2007. Reversal of resistance to cytotoxic cancer therapies: DHMEQ as a chemo-sensitizing and immuno-sensitizing agent. Drug Resist Updat. 10:1–12.

    PubMed  CAS  Google Scholar 

  • Kawanishi, S., Hiraku, Y., Pinlaor, S., and Ma, N. 2006. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem. 387:365–372.

    PubMed  CAS  Google Scholar 

  • KC, S., Carcamo, J. M., and Golde, D. W. 2006. Antioxidants prevent oxidative DNA damage and cellular transformation elicited by the over-expression of c-MYC. Mutat Res. 593:64–79.

    CAS  Google Scholar 

  • Kensler, T. W., Wakabayashi, N., and Biswal, S. 2007. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 47:89–116.

    PubMed  CAS  Google Scholar 

  • Kim, G. J., Chandrasekaran, K., and F.Morgan, W. 2006a. Mitochondrial dysfunction, persistently elevated levels of reactive oxygen species and radiation-induced genomic instability: a review. 21:361–367.

    Google Scholar 

  • Kim, H. J., Chae, H. Z., Kim, Y. J., Kim, Y. H., Hwangs, T. S., Park, E. M., and Park, Y. M. 2003. Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues. Cell Biol Toxicol. 19:285–298.

    PubMed  CAS  Google Scholar 

  • Kim, H. S., Oh, J. M., Jin, D. H., Yang, K. H., and Moon, E. Y. 2008. Paclitaxel induces vascular endothelial growth factor expression through reactive oxygen species production. Pharmacology. 81:317–324.

    PubMed  CAS  Google Scholar 

  • Kim, J. H., Bogner, P. N., Ramnath, N., Park, Y., Yu, J., and Park, Y. M. 2007. Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer. Clin Cancer Res. 13: 3875–3882.

    PubMed  CAS  Google Scholar 

  • Kim, J. W., Tchernyshyov, I., Semenza, G. L., and Dang, C. V. 2006b. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3:177–185.

    PubMed  Google Scholar 

  • Kim, S. J., Miyoshi, Y., Taguchi, T., Tamaki, Y., Nakamura, H., Yodoi, J., Kato, K., and Noguchi, S. 2005. High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer. Clin Cancer Res. 11:8425–8430.

    PubMed  CAS  Google Scholar 

  • Kim, Y.-M., Talanian, R. V., and Billiar, T. R. 1997. Nitric Oxide Inhibits Apoptosis by Preventing Increases in Caspase-3-like Activity via Two Distinct Mechanisms. J Biol Chem. 272:31138–31148.

    PubMed  CAS  Google Scholar 

  • Kinnula, V. L., and Crapo, J. D. 2004. Superoxide dismutases in malignant cells and human tumors. Free Radic Biol Med. 36:718–744.

    PubMed  CAS  Google Scholar 

  • Kissil, J. L., Walmsley, M. J., Hanlon, L., Haigis, K. M., Bender Kim, C. F., Sweet-Cordero, A., Eckman, M. S., Tuveson, D. A., Capobianco, A. J., Tybulewicz, V. L., and Jacks, T. 2007. Requirement for Rac1 in a K-ras Induced Lung Cancer in the Mouse. Cancer Res. 67:8089–8094.

    PubMed  CAS  Google Scholar 

  • Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., and Yamamoto, M. 2004. Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2. Mol Cell Biol. 24: 7130–7139.

    PubMed  CAS  Google Scholar 

  • Kobayashi, D., Watanabe, N., Yamauchi, N., Tsuji, N., Sato, T., and Niitsu, Y. 1997. Endogenous tumor necrosis factor as a predictor of doxorubicin sensitivity in leukemic patients. Blood. 89:2472–2479.

    PubMed  CAS  Google Scholar 

  • Kobayashi, M., and Yamamoto, M. 2005. Molecular Mechanisms Activating the Nrf2-Keap1 Pathway of Antioxidant Gene Regulation. Antioxid Redox Signal. 7:385–394.

    PubMed  CAS  Google Scholar 

  • Kobayashi, M., and Yamamoto, M. 2006. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Advances in Enzyme Regulation. 46: 113–140.

    PubMed  CAS  Google Scholar 

  • Kong, Q., Beel, J. A., and Lillehei, K. O. 2000. A threshold concept for cancer therapy. Med Hypotheses. 55:29–35.

    PubMed  CAS  Google Scholar 

  • Kong, Q., and Lillehei, K. O. 1998. Antioxidant inhibitors for cancer therapy. Med Hypotheses. 51:405–409.

    PubMed  CAS  Google Scholar 

  • Kopnin, P. B., Agapova, L. S., Kopnin, B. P., and Chumakov, P. M. 2007. Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up-regulation and genetic instability. Cancer Res. 67:4671–4678.

    PubMed  CAS  Google Scholar 

  • Kotlo, K. U., Yehiely, F., Efimova, E., Harasty, H., Hesabi, B., Shchors, K., Einat, P., Rozen, A., Berent, E., and Deiss, L. P. 2003. Nrf2 is an inhibitor of the Fas pathway as identified by Achilles’ Heel Method, a new function-based approach to gene identification in human cells. Oncogene. 22:797–806.

    PubMed  CAS  Google Scholar 

  • Kubbutat, M. H., Jones, S. N., and Vousden, K. H. 1997. Regulation of p53 stability by Mdm2. Nature. 387:299–303.

    PubMed  CAS  Google Scholar 

  • Kumar, B., Koul, S., Khandrika, L., Meacham, R. B., and Koul, H. K. 2008. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 68: 1777–1785.

    PubMed  CAS  Google Scholar 

  • Kundu, N., Zhang, S., and Fulton, A. M. 1995. Sublethal oxidative stress inhibits tumor cell adhesion and enhances experimental metastasis of murine mammary carcinoma. Clin Exp Metastasis. 13:16–22.

    PubMed  CAS  Google Scholar 

  • Kuninaka, S., Ichinose, Y., Koja, K., and Toh, Y. 2000. Suppression of manganese superoxide dismutase augments sensitivity to radiation, hyperthermia and doxorubicin in colon cancer cell lines by inducing apoptosis. Br J Cancer. 83:928–934.

    PubMed  CAS  Google Scholar 

  • Kwak, M. K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M., and Kensler, T. W. 2003. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J Biol Chem. 278:8135–8145.

    PubMed  CAS  Google Scholar 

  • Lai, G. M., Ozols, R. F., Young, R. C., and Hamilton, T. C. 1989. Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines. J Natl Cancer Inst. 81:535–539.

    PubMed  CAS  Google Scholar 

  • Lee, S. R., Kwon, K. S., Kim, S. R., and Rhee, S. G. 1998. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem. 273:15366–15372.

    PubMed  CAS  Google Scholar 

  • Lee, S. R., Yang, K. S., Kwon, J., Lee, C., Jeong, W., and Rhee, S. G. 2002. Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem. 277:20336–20342.

    PubMed  CAS  Google Scholar 

  • Lertratanangkoon, K., Savaraj, N., Scimeca, J. M., and Thomas, M. L. 1997. Glutathione depletion-induced thymidylate insufficiency for DNA repair synthesis. Biochem Biophys Res Commun. 234:470–475.

    PubMed  CAS  Google Scholar 

  • Li, X., Schuler, M. A., and Berenbaum, M. R. 2007. Molecular mechanisms of metabolic resistance to synthetic and natural xenobiotics. Annu Rev Entomol. 52:231–253.

    PubMed  Google Scholar 

  • Lightcap, E. S., McCormack, T. A., Pien, C. S., Chau, V., Adams, J., and Elliott, P. J. 2000. Proteasome inhibition measurements: clinical application. Clin Chem. 46:673–683.

    PubMed  CAS  Google Scholar 

  • Limoli, C. L., Giedzinski, E., Morgan, W. F., Swarts, S. G., Jones, G. D., and Hyun, W. 2003. Persistent oxidative stress in chromosomally unstable cells. Cancer Res. 63:3107–3111.

    PubMed  CAS  Google Scholar 

  • Lin, K. I., Pasinelli, P., Brown, R. H., Hardwick, J. M., and Ratan, R. R. 1999. Decreased intracellular superoxide levels activate Sindbis virus-induced apoptosis. J Biol Chem. 274:13650–13655.

    PubMed  CAS  Google Scholar 

  • Lincoln, D. T., Ali Emadi, E. M., Tonissen, K. F., and Clarke, F. M. 2003. The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Res. 23: 2425–2433.

    PubMed  CAS  Google Scholar 

  • Ling, Y. H., Liebes, L., Zou, Y., and Perez-Soler, R. 2003. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J Biol Chem. 278:33714–33723.

    PubMed  CAS  Google Scholar 

  • Lo, M., Wang, Y. Z., and Gout, P. W. 2008. The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J Cell Physiol. 215:593–602.

    PubMed  CAS  Google Scholar 

  • Lu, H., Forbes, R. A., and Verma, A. 2002. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem. 277:23111–23115.

    PubMed  CAS  Google Scholar 

  • Lu, Y. P., Lou, Y. R., Yen, P., Newmark, H. L., Mirochnitchenko, O. I., Inouye, M., and Huang, M. T. 1997. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase. Cancer Res. 57: 1468–1474.

    PubMed  CAS  Google Scholar 

  • Maki, C. G., Huibregtse, J. M., and Howley, P. M. 1996. In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res. 56:2649–2654.

    PubMed  CAS  Google Scholar 

  • Marzano, C., Gandin, V., Folda, A., Scutari, G., Bindoli, A., and Rigobello, M. P. 2007. Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells. Free Radic Biol Med. 42:872–881.

    PubMed  CAS  Google Scholar 

  • Mathas, S., Lietz, A., Janz, M., Hinz, M., Jundt, F., Scheidereit, C., Bommert, K., and Dorken, B. 2003. Inhibition of NF-kappaB essentially contributes to arsenic-induced apoptosis. Blood. 102:1028–1034.

    PubMed  CAS  Google Scholar 

  • Matheu, A., Maraver, A., Klatt, P., Flores, I., Garcia-Cao, I., Borras, C., Flores, J. M., Vina, J., Blasco, M. A., and Serrano, M. 2007. Delayed ageing through damage protection by the Arf/p53 pathway. Nature. 448:375–379.

    PubMed  CAS  Google Scholar 

  • Matsuyama, S., Llopis, J., Deveraux, Q. L., Tsien, R. Y., and Reed, J. C. 2000. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat Cell Biol. 2:318–325.

    PubMed  CAS  Google Scholar 

  • McGahon, A., Bissonnette, R., Schmitt, M., Cotter, K. M., Green, D. R., and Cotter, T. G. 1994. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood. 83:1179–1187.

    PubMed  CAS  Google Scholar 

  • Meister, A. 1988. Glutathione metabolism and its selective modification. J Biol Chem. 263: 17205–17208.

    PubMed  CAS  Google Scholar 

  • Meuillet, E. J., Mahadevan, D., Berggren, M., Coon, A., and Powis, G. 2004. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN’s lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN’s tumor suppressor activity. Arch Biochem Biophys. 429:123–133.

    PubMed  CAS  Google Scholar 

  • Miyajima, A., Nakashima, J., Yoshioka, K., Tachibana, M., Tazaki, H., and Murai, M. 1997. Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells. Br J Cancer. 76:206–210.

    PubMed  CAS  Google Scholar 

  • Morito, N., Yoh, K., Itoh, K., Hirayama, A., Koyama, A., Yamamoto, M., and Takahashi, S. 2003. Nrf2 regulates the sensitivity of death receptor signals by affecting intracellular glutathione levels. Oncogene. 22:9275–9281.

    PubMed  CAS  Google Scholar 

  • Motohashi, H., Katsuoka, F., Engel, J. D., and Yamamoto, M. 2004. Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc Natl Acad Sci U S A. 101:6379–6384.

    PubMed  CAS  Google Scholar 

  • Mu, Z. M., Yin, X. Y., and Prochownik, E. V. 2002. Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression. J Biol Chem. 277:43175–43184.

    PubMed  CAS  Google Scholar 

  • Murawaki, Y., Tsuchiya, H., Kanbe, T., Harada, K., Yashima, K., Nozaka, K., Tanida, O., Kohno, M., Mukoyama, T., Nishimuki, E., et al. 2008. Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett. 259:218–230.

    PubMed  CAS  Google Scholar 

  • Nagayama, S., Chen, Z. S., Kitazono, M., Takebayashi, Y., Niwa, K., Yamada, K., Tani, A., Haraguchi, M., Sumizawa, T., Furukawa, T., et al. 1998. Increased sensitivity to vincristine of MDR cells by the leukotriene D4 receptor antagonist, ONO-1078. Cancer Lett. 130:175–182.

    PubMed  CAS  Google Scholar 

  • Nakano, R., Oka, M., Nakamura, T., Fukuda, M., Kawabata, S., Terashi, K., Tsukamoto, K., Noguchi, Y., Soda, H., and Kohno, S. 1998. A leukotriene receptor antagonist, ONO-1078, modulates drug sensitivity and leukotriene C4 efflux in lung cancer cells expressing multidrug resistance protein. Biochem Biophys Res Commun. 251:307–312.

    PubMed  CAS  Google Scholar 

  • Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., and et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:37–43.

    PubMed  CAS  Google Scholar 

  • Nowicki, M. O., Falinski, R., Koptyra, M., Slupianek, A., Stoklosa, T., Gloc, E., Nieborowska-Skorska, M., Blasiak, J., and Skorski, T. 2004. BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood. 104: 3746–3753.

    PubMed  CAS  Google Scholar 

  • O’Brian, C. A., and Chu, F. 2005. Post-translational disulfide modifications in cell signaling--role of inter-protein, intra-protein, S-glutathionyl, and S-cysteaminyl disulfide modifications in signal transmission. Free Radic Res. 39:471–480.

    PubMed  Google Scholar 

  • O’Dwyer, P. J., LaCreta, F., Nash, S., Tinsley, P. W., Schilder, R., Clapper, M. L., Tew, K. D., Panting, L., Litwin, S., Comis, R. L., and et al. 1991. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. Cancer Res. 51:6059–6065.

    PubMed  Google Scholar 

  • Oberley, T. D., and Oberley, L. W. 1997. Antioxidant enzyme levels in cancer. Histol Histopathol. 12:525–535.

    PubMed  CAS  Google Scholar 

  • Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., and Nakatani, Y. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 87:953–959.

    PubMed  CAS  Google Scholar 

  • Oh, Y. K., Lee, T. B., and Choi, C. H. 2004. Anti-oxidant adaptation in the AML cells supersensitive to hydrogen peroxide. Biochem Biophys Res Commun. 319:41–45.

    PubMed  CAS  Google Scholar 

  • Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., and Vogelstein, B. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature. 358:80–83.

    PubMed  CAS  Google Scholar 

  • Pahl, H. L., Krauss, B., Schulze-Osthoff, K., Decker, T., Traenckner, E. B., Vogt, M., Myers, C., Parks, T., Warring, P., Muhlbacher, A., et al. 1996. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J Exp Med. 183:1829–1840.

    PubMed  CAS  Google Scholar 

  • Pan, S., and Berk, B. C. 2007. Glutathiolation regulates tumor necrosis factor-alpha-induced caspase-3 cleavage and apoptosis: key role for glutaredoxin in the death pathway. Circ Res. 100:213–219.

    PubMed  CAS  Google Scholar 

  • Pani, G., Bedogni, B., Anzevino, R., Colavitti, R., Palazzotti, B., Borrello, S., and Galeotti, T. 2000. Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells. Cancer Res. 60:4654–4660.

    PubMed  CAS  Google Scholar 

  • Patel, B. P., Rawal, U. M., Dave, T. K., Rawal, R. M., Shukla, S. N., Shah, P. M., and Patel, P. S. 2007. Lipid peroxidation, total antioxidant status, and total thiol levels predict overall survival in patients with oral squamous cell carcinoma. Integr Cancer Ther. 6:365–372.

    PubMed  CAS  Google Scholar 

  • Pelicano, H., Carney, D., and Huang, P. 2004. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 7:97–110.

    PubMed  CAS  Google Scholar 

  • Pelicano, H., Feng, L., Zhou, Y., Carew, J. S., Hileman, E. O., Plunkett, W., Keating, M. J., and Huang, P. 2003. Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J Biol Chem. 278:37832–37839.

    PubMed  CAS  Google Scholar 

  • Pelicano, H., Xu, R. H., Du, M., Feng, L., Sasaki, R., Carew, J. S., Hu, Y., Ramdas, L., Hu, L., Keating, M. J., et al. 2006. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol. 175:913–923.

    PubMed  CAS  Google Scholar 

  • Pervaiz, S. 2006. Pro-oxidant milieu blunts scissors: insight into tumor progression, drug resistance, and novel druggable targets. Curr Pharm Des. 12:4469–4477.

    PubMed  CAS  Google Scholar 

  • Pervaiz, S., Cao, J., Chao, O. S., Chin, Y. Y., and Clement, M. V. 2001. Activation of the RacGTPase inhibits apoptosis in human tumor cells. Oncogene. 20:6263–6268.

    PubMed  CAS  Google Scholar 

  • Pervaiz, S., and Clement, M. V. 2004. Tumor intracellular redox status and drug resistance--serendipity or a causal relationship? Curr Pharm Des. 10:1969–1977.

    PubMed  CAS  Google Scholar 

  • Pervaiz, S., and Clement, M. V. 2007. Superoxide anion: oncogenic reactive oxygen species? Int J Biochem Cell Biol. 39:1297–1304.

    PubMed  CAS  Google Scholar 

  • Pervaiz, S., Ramalingam, J. K., Hirpara, J. L., and Clement, M. V. 1999. Superoxide anion inhibits drug-induced tumor cell death. FEBS Lett. 459:343–348.

    PubMed  CAS  Google Scholar 

  • Pham, N. A., and Hedley, D. W. 2001. Respiratory chain-generated oxidative stress following treatment of leukemic blasts with DNA-damaging agents. Exp Cell Res. 264:345–352.

    PubMed  CAS  Google Scholar 

  • Pierce, J. W., Schoenleber, R., Jesmok, G., Best, J., Moore, S. A., Collins, T., and Gerritsen, M. E. 1997. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem. 272:21096–21103.

    PubMed  CAS  Google Scholar 

  • Pompella, A., Corti, A., Paolicchi, A., Giommarelli, C., and Zunino, F. 2007. [gamma]-Glutamyltransferase, redox regulation and cancer drug resistance. Current Opinion in Pharmacology. 7:360–366.

    PubMed  CAS  Google Scholar 

  • Pouyssegur, J., and Mechta-Grigoriou, F. 2006. Redox regulation of the hypoxia-inducible factor. Biol Chem. 387:1337–1346.

    PubMed  CAS  Google Scholar 

  • Powis, G., and Kirkpatrick, D. L. 2007. Thioredoxin signaling as a target for cancer therapy. Curr Opin Pharmacol. 7:392–397.

    PubMed  CAS  Google Scholar 

  • Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Nieto, M. A., et al. 2005. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature. 436:123–127.

    PubMed  CAS  Google Scholar 

  • Raffel, J., Bhattacharyya, A. K., Gallegos, A., Cui, H., Einspahr, J. G., Alberts, D. S., and Powis, G. 2003. Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival. J Lab Clin Med. 142:46–51.

    PubMed  CAS  Google Scholar 

  • Rahman, I., Marwick, J., and Kirkham, P. 2004. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol. 68:1255–1267.

    PubMed  CAS  Google Scholar 

  • Ramanathan, B., Jan, K. Y., Chen, C. H., Hour, T. C., Yu, H. J., and Pu, Y. S. 2005. Resistance to paclitaxel is proportional to cellular total antioxidant capacity. Cancer Res. 65:8455–8460.

    PubMed  CAS  Google Scholar 

  • Ramanathan, R. K., Kirkpatrick, D. L., Belani, C. P., Friedland, D., Green, S. B., Chow, H. H., Cordova, C. A., Stratton, S. P., Sharlow, E. R., Baker, A., and Dragovich, T. 2007. A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors. Clin Cancer Res. 13:2109–2114.

    PubMed  CAS  Google Scholar 

  • Rigobello, M. P., Folda, A., Baldoin, M. C., Scutari, G., and Bindoli, A. 2005. Effect of auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase. Free Radic Res. 39:687–695.

    PubMed  CAS  Google Scholar 

  • Rivera, A., and Maxwell, S. A. 2005. The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J Biol Chem. 280:29346–29354.

    PubMed  CAS  Google Scholar 

  • Rosell, R., Cecere, F., Santarpia, M., Reguart, N., and Taron, M. 2006. Predicting the outcome of chemotherapy for lung cancer. Curr Opin Pharmacol. 6:323–331.

    PubMed  CAS  Google Scholar 

  • Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., and Chumakov, P. M. 2005. The antioxidant function of the p53 tumor suppressor. Nat Med. 11: 1306–1313.

    PubMed  CAS  Google Scholar 

  • Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., and Ichijo, H. 1998. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. Embo J. 17:2596–2606.

    PubMed  CAS  Google Scholar 

  • Salinas, A. E., and Wong, M. G. 1999. Glutathione S-transferases--a review. Curr Med Chem. 6:279–309.

    PubMed  CAS  Google Scholar 

  • Sanchez, M., Torres, J. V., Tormos, C., Iradi, A., Muniz, P., Espinosa, O., Salvador, A., Rodriguez-Delgado, J., Fandos, M., and Saez, G. T. 2006. Impairment of antioxidant enzymes, lipid peroxidation and 8-oxo-2'-deoxyguanosine in advanced epithelial ovarian carcinoma of a Spanish community. Cancer Lett. 233:28–35.

    PubMed  CAS  Google Scholar 

  • Sattler, M., Verma, S., Shrikhande, G., Byrne, C. H., Pride, Y. B., Winkler, T., Greenfield, E. A., Salgia, R., and Griffin, J. D. 2000. The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. J Biol Chem. 275:24273–24278.

    PubMed  CAS  Google Scholar 

  • Saydam, N., Kirb, A., Demir, O., Hazan, E., Oto, O., Saydam, O., and Guner, G. 1997. Determination of glutathione, glutathione reductase, glutathione peroxidase and glutathione S-transferase levels in human lung cancer tissues. Cancer Lett. 119:13–19.

    PubMed  CAS  Google Scholar 

  • Schneider, B. L., and Kulesz-Martin, M. 2004. Destructive cycles: the role of genomic instability and adaptation in carcinogenesis. Carcinogenesis. 25:2033–2044.

    PubMed  CAS  Google Scholar 

  • Schroder, C. P., Godwin, A. K., O’Dwyer, P. J., Tew, K. D., Hamilton, T. C., and Ozols, R. F. 1996. Glutathione and drug resistance. Cancer Invest. 14:158–168.

    PubMed  CAS  Google Scholar 

  • Schubbert, S., Shannon, K., and Bollag, G. 2007. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer. 7:295–308.

    PubMed  CAS  Google Scholar 

  • Sen, C. K., and Packer, L. 1996. Antioxidant and redox regulation of gene transcription. Faseb J. 10:709–720.

    PubMed  CAS  Google Scholar 

  • Serrano, J., Palmeira, C. M., Kuehl, D. W., and Wallace, K. B. 1999. Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration. Biochim Biophys Acta. 1411:201–205.

    PubMed  CAS  Google Scholar 

  • Sgambato, A., Camerini, A., Pani, G., Cangiano, R., Faraglia, B., Bianchino, G., De Bari, B., Galeotti, T., and Cittadini, A. 2003. Increased expression of cyclin E is associated with an increased resistance to doxorubicin in rat fibroblasts. Br J Cancer. 88:1956–1962.

    PubMed  CAS  Google Scholar 

  • Sharma, M., He, Q. Y., and Tomasz, M. 1994. Effects of glutathione on alkylation and cross-linking of DNA by mitomycin C. Isolation of a ternary glutathione-mitomycin-DNA adduct. Chem Res Toxicol. 7:401–407.

    PubMed  CAS  Google Scholar 

  • Shaulian, E., and Karin, M. 2002. AP-1 as a regulator of cell life and death. Nat Cell Biol. 4: E131–136.

    PubMed  CAS  Google Scholar 

  • Shaulian, E., Schreiber, M., Piu, F., Beeche, M., Wagner, E. F., and Karin, M. 2000. The Mammalian UV Response: c-Jun Induction Is Required for Exit from p53-Imposed Growth Arrest. Cell. 103:897–907.

    PubMed  CAS  Google Scholar 

  • Shishodia, S., and Aggarwal, B. B. 2004. Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J Biol Chem. 279:47148–47158.

    PubMed  CAS  Google Scholar 

  • Siedle, B., Garcia-Pineres, A. J., Murillo, R., Schulte-Monting, J., Castro, V., Rungeler, P., Klaas, C. A., Da Costa, F. B., Kisiel, W., and Merfort, I. 2004. Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-kappaB. J Med Chem. 47:6042–6054.

    PubMed  CAS  Google Scholar 

  • Smirnov, A. S., Ruzov, A. S., Budanov, A. V., Prokhortchouk, A. V., Ivanov, A. V., and Prokhortchouk, E. B. 2001. High constitutive level of NF-kappaB is crucial for viability of adenocarcinoma cells. Cell Death Differ. 8:621–630.

    PubMed  CAS  Google Scholar 

  • Soussi, T. 2003. p53 mutations and resistance to chemotherapy: A stab in the back for p73. Cancer Cell. 3:303–305.

    PubMed  CAS  Google Scholar 

  • Spitz, D. R., Phillips, J. W., Adams, D. T., Sherman, C. M., Deen, D. F., and Li, G. C. 1993. Cellular resistance to oxidative stress is accompanied by resistance to cisplatin: the significance of increased catalase activity and total glutathione in hydrogen peroxide-resistant fibroblasts. J Cell Physiol. 156:72–79.

    PubMed  CAS  Google Scholar 

  • Spitz, D. R., Sim, J. E., Ridnour, L. A., Galoforo, S. S., and Lee, Y. J. 2000. Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism? Ann N Y Acad Sci. 899:349–362.

    PubMed  CAS  Google Scholar 

  • Stacy, D. R., Ely, K., Massion, P. P., Yarbrough, W. G., Hallahan, D. E., Sekhar, K. R., and Freeman, M. L. 2006. Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas. Head Neck. 28:813–818.

    PubMed  Google Scholar 

  • Suh, Y. A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., and Lambeth, J. D. 1999. Cell transformation by the superoxide-generating oxidase Mox1. Nature. 401:79–82.

    PubMed  CAS  Google Scholar 

  • Sullivan, R., and Graham, C. H. 2008. Chemosensitization of cancer by nitric oxide. Curr Pharm Des. 14:1113–1123.

    PubMed  CAS  Google Scholar 

  • Sun, J., Steenbergen, C., and Murphy, E. 2006. S-Nitrosylation: NO-Related Redox Signaling to Protect Against Oxidative Stress. Antioxid Redox Signal. 8:1693–1705.

    PubMed  CAS  Google Scholar 

  • Suzuki, S., Higuchi, M., Proske, R. J., Oridate, N., Hong, W. K., and Lotan, R. 1999. Implication of mitochondria-derived reactive oxygen species, cytochrome C and caspase-3 in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. Oncogene. 18: 6380–6387.

    PubMed  CAS  Google Scholar 

  • Swartz, H. M., and Gutierrez, P. L. 1977. Free radical increases in cancer: evidence that there is not a real increase. Science. 198:936–938.

    PubMed  CAS  Google Scholar 

  • Szatrowski, T. P., and Nathan, C. F. 1991. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51:794–798.

    PubMed  CAS  Google Scholar 

  • Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., and Harris, A. L. 2000. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol. 157:411–421.

    PubMed  CAS  Google Scholar 

  • Teicher, B. A., Holden, S. A., Herman, T. S., Sotomayor, E. A., Khandekar, V., Rosbe, K. W., Brann, T. W., Korbut, T. T., and Frei, E., 3rd 1991. Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II). Int J Cancer. 47:252–260.

    PubMed  CAS  Google Scholar 

  • Tew, K. D. 1994. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 54:4313–4320.

    PubMed  CAS  Google Scholar 

  • Tew, K. D. 2007. Redox in redux: Emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation. Biochem Pharmacol. 73:1257–1269.

    PubMed  CAS  Google Scholar 

  • Tiligada, E. 2006. Chemotherapy: induction of stress responses. Endocr Relat Cancer. 13 Suppl 1:S115–124.

    PubMed  CAS  Google Scholar 

  • Tohyama, Y., Takano, T., and Yamamura, H. 2004. B cell responses to oxidative stress. Curr Pharm Des. 10:835–839.

    PubMed  CAS  Google Scholar 

  • Tomko, R. J., Jr., Bansal, P., and Lazo, J. S. 2006. Airing out an antioxidant role for the tumor suppressor p53. Mol Interv. 6:23–25, 22.

    PubMed  CAS  Google Scholar 

  • Tosetti, F., Vene, R., Arena, G., Morini, M., Minghelli, S., Noonan, D. M., and Albini, A. 2003. N-(4-hydroxyphenyl)retinamide inhibits retinoblastoma growth through reactive oxygen species-mediated cell death. Mol Pharmacol. 63:565–573.

    PubMed  CAS  Google Scholar 

  • Townsend, D. M., and Tew, K. D. 2003. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene. 22:7369–7375.

    PubMed  CAS  Google Scholar 

  • Trachootham, D., Lu, W., Ogasawara, M. A., Nilsa, R. D., and Huang, P. 2008a. Redox regulation of cell survival. Antioxid Redox Signal. 10:1343–1374.

    PubMed  CAS  Google Scholar 

  • Trachootham, D., Zhang, H., Zhang, W., Feng, L., Du, M., Zhou, Y., Chen, Z., Pelicano, H., Plunkett, W., Wierda, W. G., et al. 2008b. Effective Elimination of Fludarabine-Resistant CLL Cells by PEITC through a Redox-Mediated Mechanism. Blood.

    Google Scholar 

  • Trachootham, D., Zhou, Y., Zhang, H., Demizu, Y., Chen, Z., Pelicano, H., Chiao, P. J., Achanta, G., Arlinghaus, R. B., Liu, J., and Huang, P. 2006. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell. 10:241–252.

    PubMed  CAS  Google Scholar 

  • Tsang, W. P., Chau, S. P., Kong, S. K., Fung, K. P., and Kwok, T. T. 2003. Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis. Life Sci. 73:2047–2058.

    PubMed  CAS  Google Scholar 

  • Tsao, S. M., Yin, M. C., and Liu, W. H. 2007. Oxidant stress and B vitamins status in patients with non-small cell lung cancer. Nutr Cancer. 59:8–13.

    PubMed  CAS  Google Scholar 

  • Turella, P., Cerella, C., Filomeni, G., Bullo, A., De Maria, F., Ghibelli, L., Ciriolo, M. R., Cianfriglia, M., Mattei, M., Federici, G., et al. 2005. Proapoptotic activity of new glutathione S-transferase inhibitors. Cancer Res. 65:3751–3761.

    PubMed  CAS  Google Scholar 

  • Turpaev, K. T. 2002. Reactive Oxygen Species and Regulation of Gene Expression. Biochemistry (Moscow). 67:281–292.

    CAS  Google Scholar 

  • Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., and Wahl, G. M. 2002. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell. 9: 1031–1044.

    PubMed  CAS  Google Scholar 

  • Venugopal, R., and Jaiswal, A. K. 1998. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene. 17:3145–3156.

    PubMed  CAS  Google Scholar 

  • Vermeulen, L., Vanden Berghe, W., and Haegeman, G. 2006. Regulation of NF-kappaB transcriptional activity. Cancer Treat Res. 130:89–102.

    PubMed  CAS  Google Scholar 

  • Vita, M., and Henriksson, M. 2006. The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol. 16:318–330.

    PubMed  CAS  Google Scholar 

  • Vogel, A., Aslan, J. E., Willenbring, H., Klein, C., Finegold, M., Mount, H., Thomas, G., and Grompe, M. 2006. Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases. Gastroenterology. 130:104–119.

    PubMed  CAS  Google Scholar 

  • Wang, X. J., Sun, Z., Villeneuve, N. F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G. T., et al. 2008a. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis. 29:1235–1243.

    PubMed  CAS  Google Scholar 

  • Wang, X. J., Sun, Z., Villeneuve, N. F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G. T., et al. 2008b. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis.

    Google Scholar 

  • Wang, Y., Saad, M., Pakunlu, R. I., Khandare, J. J., Garbuzenko, O. B., Vetcher, A. A., Soldatenkov, V. A., Pozharov, V. P., and Minko, T. 2008c. Nonviral Nanoscale-Based Delivery of Antisense Oligonucleotides Targeted to Hypoxia-Inducible Factor 1{alpha} Enhances the Efficacy of Chemotherapy in Drug-Resistant Tumor. Clin Cancer Res. 14:3607–3616.

    PubMed  CAS  Google Scholar 

  • Wang, Y., and Minko, T. 2004. A novel cancer therapy: combined liposomal hypoxia inducible factor 1 alpha antisense oligonucleotides and an anticancer drug. Biochem Pharmacol. 68(10):2031–2042.

    Google Scholar 

  • Wek, R. C., and Cavener, D. R. 2007. Translational control and the unfolded protein response. Antioxid Redox Signal. 9:2357–2371.

    PubMed  CAS  Google Scholar 

  • Welsh, S., Williams, R., Kirkpatrick, L., Paine-Murrieta, G., and Powis, G. 2004. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha. Mol Cancer Ther. 3:233–244.

    PubMed  CAS  Google Scholar 

  • Welsh, S. J., Bellamy, W. T., Briehl, M. M., and Powis, G. 2002. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res. 62:5089–5095.

    PubMed  CAS  Google Scholar 

  • Weng, Q., Wang, D., Guo, P., Fang, L., Hu, Y., He, Q., and Yang, B. 2008. Q39, a novel synthetic Quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia. Eur J Pharmacol. 581:262–269.

    PubMed  CAS  Google Scholar 

  • Wesarg, E., Hoffarth, S., Wiewrodt, R., Kroll, M., Biesterfeld, S., Huber, C., and Schuler, M. 2007. Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer. Int J Cancer. 121:2387–2394.

    PubMed  CAS  Google Scholar 

  • Wilk, S., and Figueiredo-Pereira, M. E. 1993. Synthetic inhibitors of the multicatalytic proteinase complex (proteasome). Enzyme Protein. 47:306–313.

    PubMed  CAS  Google Scholar 

  • Wu, W. S. 2006. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 25:695–705.

    PubMed  CAS  Google Scholar 

  • Xia, Y. F., Ye, B. Q., Li, Y. D., Wang, J. G., He, X. J., Lin, X., Yao, X., Ma, D., Slungaard, A., Hebbel, R. P., et al. 2004. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol. 173:4207–4217.

    PubMed  CAS  Google Scholar 

  • Xu, C., Shen, G., Chen, C., Gelinas, C., and Kong, A. N. 2005. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. Oncogene. 24:4486–4495.

    PubMed  CAS  Google Scholar 

  • Yamakawa, H., Ito, Y., Naganawa, T., Banno, Y., Nakashima, S., Yoshimura, S., Sawada, M., Nishimura, Y., Nozawa, Y., and Sakai, N. 2000. Activation of caspase-9 and -3 during H2O2-induced apoptosis of PC12 cells independent of ceramide formation. Neurol Res. 22:556–564.

    PubMed  CAS  Google Scholar 

  • Yi, J., Yang, J., He, R., Gao, F., Sang, H., Tang, X., and Ye, R. D. 2004. Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. Cancer Res. 64:108–116.

    PubMed  CAS  Google Scholar 

  • Young, T. W., Mei, F. C., Yang, G., Thompson-Lanza, J. A., Liu, J., and Cheng, X. 2004. Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry. Cancer Res. 64: 4577–4584.

    PubMed  CAS  Google Scholar 

  • Yu, C. X., Li, S., and Whorton, A. R. 2005. Redox regulation of PTEN by S-nitrosothiols. Mol Pharmacol. 68:847–854.

    PubMed  CAS  Google Scholar 

  • Zhang, H., Trachootham, D., Lu, W., Carew, J., Giles, F. J., Keating, M. J., Arlinghaus, R. B., and Huang, P. 2008. Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism. Leukemia. 22:1191–1199.

    PubMed  CAS  Google Scholar 

  • Zhong, H., De Marzo, A. M., Laughner, E., Lim, M., Hilton, D. A., Zagzag, D., Buechler, P., Isaacs, W. B., Semenza, G. L., and Simons, J. W. 1999. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59:5830–5835.

    PubMed  CAS  Google Scholar 

  • Zhou, Y., Hileman, E. O., Plunkett, W., Keating, M. J., and Huang, P. 2003. Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood. 101:4098–4104.

    PubMed  CAS  Google Scholar 

  • Zurer, I., Hofseth, L. J., Cohen, Y., Xu-Welliver, M., Hussain, S. P., Harris, C. C., and Rotter, V. 2004. The role of p53 in base excision repair following genotoxic stress. Carcinogenesis. 25:11–19.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA

    Dunyaporn Trachootham & Wan Zhang

  2. Department of Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 0951, Houston, TX 77030, USA

    Peng Huang

Authors
  1. Dunyaporn Trachootham
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peng Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peng Huang .

Editor information

Editors and Affiliations

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2009 Springer Science+Business Media, LLC

    About this chapter

    Cite this chapter

    Trachootham, D., Zhang, W., Huang, P. (2009). Oxidative Stress and Drug Resistance in Cancer. In: Siddik, Z., Mehta, K. (eds) Drug Resistance in Cancer Cells. Springer, New York, NY. https://doi.org/10.1007/978-0-387-89445-4_7

    Download citation

    Publish with us

    Policies and ethics

    Search

    Navigation